Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Mesothelioma, Secondary cancers
Closed
Phase 3
This trial is comparing volrustomig and chemotherapy with for mesothelioma of the lungs.
Volrustomig is pronounced vol-rus-to-mig. It is also called MEDI5752.
This trial is for people:
having their first treatment for mesothelioma of the lungs and
whose mesothelioma has spread elsewhere in the body and it isn’t possible to remove it with surgery
Recruitment start: 25 November 2023
Recruitment end: 22 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Dean Fennell
AstraZeneca
Last reviewed: 01 Apr 2026
CRUK internal database number: 19621
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
